ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLL Cello Health Plc

161.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 161.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cello Health PLC Director/PDMR Dealings and Total Voting Rights (5783P)

29/05/2018 3:45pm

UK Regulatory


Cello Health (LSE:CLL)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cello Health Charts.

TIDMCLL

RNS Number : 5783P

Cello Health PLC

29 May 2018

29 May 2018

Cello Health plc

("Cello" or "the Company")

Director / PDMR Dealings and Total Voting Rights

The Company notifies that, on 25 May 2018, Richard Marsham and Minh Huynh, both of whom are persons discharging managerial responsibilities of the Company, exercised options over 46,000, and 15,321 ordinary shares of 10 pence each ("Shares") in the capital of the Company respectively. The new Shares will rank pari-passu with existing Shares and have been admitted to trading under the Company's existing block listing. The exercise prices paid were as follows:

 
 Name               Number of            Exercise price    Type of option 
                     options exercised    paid per share    scheme 
                                          (p) 
-----------------  -------------------  ----------------  ---------------- 
                                                           Approved Share 
 Richard Marsham    17,428               42                 Option Plan 
-----------------  -------------------  ----------------  ---------------- 
                                                           PSP Option 
 Richard Marsham    16,000               10                 Scheme 
-----------------  -------------------  ----------------  ---------------- 
                                                           Unapproved 
 Richard Marsham    12,572               42                 Option Plan 
-----------------  -------------------  ----------------  ---------------- 
                                                           Approved Option 
 Minh Huynh         15,321               50                 Plan 
-----------------  -------------------  ----------------  ---------------- 
 

Following the above exercise of options, Richard Marsham and Minh Huynh sold 46,000 and 15,321 Shares respectively, all at a price of 122 pence per share.

Following the issue of the new Shares, Cello's issued share capital will comprise 105,112,253 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 104,659,253 Ordinary Shares.

The above figure of 104,659,253 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

 
 Cello Health plc                  020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Finance Director 
 
 Cenkos Securities plc             0207 397 8900 
 Mark Connelly 
  Harry Hargreaves 
 
 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------------------------- 
 a)    Name                        Richard Marsham 
----  --------------------------  ---------------------------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------------------------- 
 a)    Position/status             PDMR and director of Cello 
                                    Signal 
----  --------------------------  ---------------------------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------------------------- 
 a)    Name                        Cello Health plc 
----  --------------------------  ---------------------------------------------- 
 b)    LEI                         2138004TZYGZLWQP7N64 
----  --------------------------  ---------------------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------------------------- 
 a)    Description of              Options over ordinary shares 
        the financial               of 10 pence each 
        instrument, type 
        of instrument 
---- 
       Identification              ISIN: GB00B0310763 
        code 
----  --------------------------  ---------------------------------------------- 
 b)    Nature of the                    1. Exercise of options over 
        transaction                      Ordinary Shares of 10 pence 
                                         each, pursuant to Approved 
                                         Share Option Plan 
                                         2. Exercise of options over 
                                         Ordinary Shares of 10 pence 
                                         each, pursuant to PSP Option 
                                         Scheme 
                                         3. Exercise of options over 
                                         Ordinary Shares of 10 pence 
                                         each, pursuant to Unapproved 
                                         Option Plan 
                                         4. Sale of Ordinary Shares 
----  --------------------------  ---------------------------------------------- 
 c)    Price(s) and volume(s) 
----                                   ------------------  ---------------- 
                                        Price(s)            Volume(s) 
----                                   ------------------  ---------------- 
                                             1. 42p per          1. 17,428 
                                              share 
                                              2. 10p per          2. 16,000 
                                               share 
                                              3. 42p per          3. 12,572 
                                               share 
                                              4. 122p per         4. 42,000 
                                               share 
                                       ------------------  ---------------- 
 
 d)    Aggregated information 
---- 
 
  - Aggregated volume              46,000 
 
  - Price                          Weighted average exercise 
                                    price of 30.87p per share 
 
 e)    Date of the transaction     25 May 2018 
----  --------------------------  ---------------------------------------------- 
 f)    Place of the transaction         1,2,3 - Outside trading 
                                         venue 
                                         4. London Stock Exchange 
----  --------------------------  ---------------------------------------------- 
 
 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------------------- 
 a)   Name                       Minh Huynh 
---  -------------------------  ---------------------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------------------------- 
 a)   Position/status            PDMR and director of Cello 
                                  Signal 
---  -------------------------  ---------------------------------------------------- 
 b)   Initial notification       Initial notification 
       /Amendment 
---  -------------------------  ---------------------------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------- 
 a)   Name                       Cello Health plc 
---  -------------------------  ---------------------------------------------------- 
 b)   LEI                        2138004TZYGZLWQP7N64 
---  -------------------------  ---------------------------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------------------------- 
 a)   Description of             Options over ordinary shares 
       the financial              of 10 pence each 
       instrument, type 
       of instrument 
--- 
      Identification             ISIN: GB00B0310763 
       code 
---  -------------------------  ---------------------------------------------------- 
 b)   Nature of the                   1. Exercise of options over 
       transaction                     Ordinary Shares of 10 pence 
                                       each, pursuant to Approved 
                                       Share Option Plan 
                                       2. Sale of Ordinary Shares 
---  -------------------------  ---------------------------------------------------- 
 c)   Price(s) and volume(s) 
---                                  ------------------  ---------------------- 
                                      Price(s)            Volume(s) 
---                                  ------------------  ---------------------- 
                                           1. 50p per                1. 15,321 
                                            share 
                                            2. 122p per               2. 15,321 
                                             share 
                                     ------------------  ---------------------- 
 
 d)   Aggregated information     N/A - single transaction 
--- 
 
      - Aggregated volume 
 
      - Price 
 
 e)   Date of the transaction    25 May 2018 
---  -------------------------  ---------------------------------------------------- 
 f)   Place of the transaction        1. Outside trading venue 
                                       2. London Stock Exchange 
---  -------------------------  ---------------------------------------------------- 
 

About Cello Health plc

We are a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. We currently service 24 of the top 25 pharmaceutical clients globally as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

We enable clients to differentiate their propositions and drive brand success in ever more complex global markets. We deliver our services through nearly 1,000 highly skilled professionals utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York, Philadelphia, London, Edinburgh, Farnham and Cheltenham.

For further information, please visit: https://cellohealthplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFKCDQQBKDQPB

(END) Dow Jones Newswires

May 29, 2018 10:45 ET (14:45 GMT)

1 Year Cello Health Chart

1 Year Cello Health Chart

1 Month Cello Health Chart

1 Month Cello Health Chart

Your Recent History

Delayed Upgrade Clock